Rhythm Biosciences Limited (ASX:RHY)

Rhythm Biosciences Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	1.4	0.71	4.12	7.55	2.23
Short-Term Investments	0.09	0.05	0.05	0.05	0.05
Cash & Short-Term Investments	1.48	0.75	4.17	7.6	2.27
Cash Growth	96.45%	-81.90%	-45.11%	234.10%	23.36%
Accounts Receivable	0.06	0.04	-	-	-
Other Receivables	-	-	0.07	0.08	0.16
Receivables	0.06	0.04	0.07	0.08	0.16
Inventory	0.07	-	2.77	-	-
Prepaid Expenses	0.19	0.09	0.12	0.09	0.06
Total Current Assets	1.81	0.89	7.12	7.77	2.49
Property, Plant & Equipment	0.17	0.28	0.19	0.24	0.11
Goodwill	0.53	-	-	-	-
Other Intangible Assets	0.32	0.35	0.39	0.43	0.46
Total Assets	2.83	1.52	7.7	8.44	3.07
Accounts Payable	0.53	0.21	1.33	0.28	0.6
Accrued Expenses	0.52	0.27	0.35	0.57	0.74
Current Portion of Long-Term Debt	1	-	-	-	-
Current Portion of Leases	0.11	0.08	0.08	0.09	-
Total Current Liabilities	2.16	0.56	1.77	0.93	1.34
Long-Term Leases	0	0.09	-	0.08	-
Other Long-Term Liabilities	0.01	0	0.06	0.05	0.02
Total Liabilities	2.17	0.65	1.82	1.07	1.36
Common Stock	37.75	34.45	31.55	27.83	15.98
Retained Earnings	-42.5	-38.67	-31.82	-23.6	-14.81
Comprehensive Income & Other	5.41	5.09	6.14	3.14	0.53
Shareholders' Equity	0.66	0.87	5.87	7.37	1.71
Total Liabilities & Equity	2.83	1.52	7.7	8.44	3.07
Total Debt	1.11	0.16	0.08	0.17	-
Net Cash (Debt)	0.37	0.59	4.08	7.43	2.27
Net Cash Growth	-36.52%	-85.54%	-44.99%	226.62%	26.26%
Net Cash Per Share	0.00	0.00	0.02	0.04	0.01
Filing Date Shares Outstanding	284.08	248.6	220.92	214.18	202.25
Total Common Shares Outstanding	290.33	248.6	219.79	214.18	202.17
Working Capital	-0.35	0.32	5.35	6.84	1.15
Book Value Per Share	0.00	0.00	0.03	0.03	0.01
Tangible Book Value	-0.19	0.51	5.48	6.95	1.24
Tangible Book Value Per Share	-0.00	0.00	0.02	0.03	0.01
Machinery	-	-	0.37	0.28	0.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.